Riskpilot← Back to searchSign inGet full accessUNICARE COPERIO AS
ASActiveOrg 985311013Prinsens Gate 39, 7011 TrondheimOther human health activities n.e.c. · NACE 8699Est. 200320 employees
Revenue 2024
NOK 42,9M
-36% vs 2023
EBITDA margin
-17.0%
-205% vs 2023
Equity ratio
18.0%
Financial strength
Net profit 2024
NOK -6,5M
-114% vs 2023
| Revenue | NOK 42,9M | -36% |
| EBITDA | NOK -7,3M | -205% |
| Net profit | NOK -6,5M | -114% |
| Total assets | NOK 15,2M | -12% |
| Equity | NOK 2,7M | -14% |
| Employees | 20 | — |
Legal name
UNICARE COPERIO AS
Org number
985311013
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
30. januar 2003
Share capital
NOK 100 000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Virksomhet eller investeringer innen helse- og omsorgstjenester, samt tilknyttede områder inkludert fast eiendom.
Address
Prinsens Gate 39, 7011 Trondheim
Phone
+4773929230
Email
adm@coperio.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28 878 | 31 910 | 36 073 | 26 452 | 26 378 | 25 675 | 23 781 | 34 305 | 47 307 | 66 714 | 42 853 |
| Staff expenses | −13 654 | −13 752 | −16 513 | −14 113 | −13 922 | −16 313 | −11 659 | −15 391 | −24 203 | −34 678 | −25 759 |
| EBITDA | 1 763 | 4 688 | 6 315 | 3 697 | 4 468 | 633 | 3 752 | 6 464 | 2 986 | −2 387 | −7 271 |
| Depreciation & amort. | −81 | −35 | −31 | −25 | −85 | −145 | −198 | −954 | −1 025 | −1 360 | −679 |
| EBIT | 1 682 | 4 653 | 6 284 | 3 672 | 4 383 | 487 | 3 553 | 5 510 | 1 961 | −3 747 | −7 950 |
| Net financials | 2 | 41 | 117 | 183 | 289 | 348 | 426 | 578 | −228 | −108 | −287 |
| Profit before tax | 1 684 | 4 694 | 6 402 | 3 855 | 4 672 | 835 | 3 980 | 6 088 | 1 732 | −3 855 | −8 237 |
| Tax | 339 | 1 117 | 1 374 | 722 | 873 | −77 | 764 | 1 304 | 387 | −839 | −1 773 |
| Net profit | 1 345 | 3 577 | 5 027 | 3 134 | 3 799 | 912 | 3 215 | 4 785 | 1 345 | −3 016 | −6 464 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 14 320 | 19 897 | 26 291 | 26 499 | 22 395 | 26 845 | 31 507 | 28 387 | 12 219 | 17 321 | 15 203 |
| Equity | 4 753 | 7 340 | 9 893 | 11 506 | 11 995 | 10 407 | 11 282 | 16 067 | 2 861 | 3 200 | 2 741 |
| Long-term debt | 0 | 1 340 | 5 340 | 5 892 | 2 492 | 3 952 | 3 085 | 2 136 | 1 697 | 969 | 447 |
| Short-term debt | 9 567 | 11 217 | 11 059 | 9 101 | 7 908 | 12 124 | 16 652 | 9 859 | 7 536 | 13 152 | 12 015 |
| Total debt | 9 567 | 12 557 | 16 399 | 14 993 | 10 399 | 16 076 | 19 737 | 11 995 | 9 233 | 14 121 | 12 462 |
EBITDA margin
-17.0%
This company
15.8%
Market median
-208% vs market
20142024
Equity ratio
18.0%
This company
38.2%
Market median
-53% vs market
20142024
Return on equity
-235.8%
This company
18.4%
Market median
-1382% vs market
20142024
Net profit margin
-15.1%
This company
8.1%
Market median
-286% vs market
20142024
Asset turnover
2.82×
This company
1.12×
Market median
+152% vs market
20142024
Debt / equity
4.55×
This company
0.62×
Market median
-634% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JV Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
LT Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
TS Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
UR Deputy Member | Deputy Member | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2010 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Unicare Helsepartner As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Unicare As
UNICARE COPERIO AS Board members of UNICARE COPERIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Julie Vister Nordbø | Chief Executive Officer | 0 companies |
| Lill Tove Gimnes | Chief Executive Officer | 0 companies |
| Torben Stiles Jenssen | Chief Executive Officer | 0 companies |
| Ulla Rimmer Stiles | Deputy Member | 0 companies |
| Trine Sjøvold | Board of Directors | 0 companies |
| Knut Øversjøen | Board of Directors | 0 companies |
| Tore Charles Stiles | Chairman | 0 companies |
| Lars Erik Baustad | Chairman | 0 companies |
| Ole Mjåtvedt | Chairman | 0 companies |